Cisplatin has been in shortage since February 2023 (per FDA data), and the shortage has grown particularly acute in the last week or two. The American Society of Clinical Onology (ASCO) has the following information from the Food and Drug Administration (FDA) regarding cisplatin availability:
Accord/Intas released the following cisplatin lot this week:
NDC |
Lot # |
Product Name |
16729-288-11 |
P2205697 |
CISPLATIN INJECTION 1MG/ML 50ML VIAL |
Subsequent releases are expected.
Please check the FDA's drug shortage list for up-to-date information on availability and releases.
Check ASCO in Action for updates as well as news, advocacy, and analysis on cancer policy.